| Bioactivity | Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3]. | ||||||
| Invitro | The antagonist of histamine H2-receptors, Cimetidine inhibits the stimulatory effect of histamine in vitro and activates Tetragastrin stimulation of the adenylate cyclase activity. Tetragastrin and histamine activate adenylate cyclase of the rat gastric mucosa via different receptors[4]. | ||||||
| Name | Tetragastrin | ||||||
| CAS | 1947-37-1 | ||||||
| Shortening | WMDF-NH2 | ||||||
| Formula | C29H36N6O6S | ||||||
| Molar Mass | 596.70 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Tetragastrin
CAS: 1947-37-1 F: C29H36N6O6S W: 596.70
Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.